Home › Funds › Boxer Capital Management, LLC › CRVS

Boxer Capital Management, LLC position in CRVS

CORVUS PHARMACEUTICALS I · Health Care

Boxer Capital Management, LLC reported holding 1,100,000 shares of CRVS (CORVUS PHARMACEUTICALS I) in its Q2 2026 13F filing — a position valued at US$16.4M, representing 1.24% of its reported portfolio and ranking #19 among its reported holdings. Boxer Capital Management, LLC has disclosed CRVS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.10M sh
Reported value held$16.43M
Portfolio Weight1.24%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's CRVS position evolved

Boxer Capital Management, LLC first disclosed a stake in CRVS in Q1 2026 at 1,100,000 shares (US$16.1M). The position peaked in Q2 2026 at 1,100,000 shares, worth US$16.4M. Across 2 filings, Boxer Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,100,000 shares valued at US$16.4M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.10M $16.09M New
Q2 2026 1.10M $16.43M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRVS and 13F data

CRVS (CORVUS PHARMACEUTICALS I) is a Health Care company. 72 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), Vivo Capital, LLC (US$41.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRVS

All CRVS fund holders →

FAQ

How long has Boxer Capital Management, LLC held CRVS?

Boxer Capital Management, LLC has disclosed CRVS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Boxer Capital Management, LLC's current position in CRVS?

As of Q2 2026, Boxer Capital Management, LLC holds 1.10M shares of CRVS (CORVUS PHARMACEUTICALS I), valued at $16.43M, representing 1.24% of its reported portfolio and ranking #19.

Has Boxer Capital Management, LLC been buying or selling CRVS?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in CRVS. The position peaked in Q2 2026 at 1.10M shares.

Which other funds hold CRVS?

Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Vivo Capital, LLC, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.